These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26973275)

  • 1. Inflammatory Biomarkers and Atherosclerosis.
    Soeki T; Sata M
    Int Heart J; 2016; 57(2):134-9. PubMed ID: 26973275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of inflammation and their clinical significance.
    Ballantyne CM; Nambi V
    Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression.
    Siasos G; Tsigkou V; Oikonomou E; Zaromitidou M; Tsalamandris S; Mourouzis K; Vavuranakis M; Anastasiou M; Vlasis K; Limperi M; Gennimata V; Boletis JN; Papavassiliou AG; Tousoulis D
    Curr Med Chem; 2015; 22(22):2619-35. PubMed ID: 25876747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.
    Ferri C; Croce G; Cofini V; De Berardinis G; Grassi D; Casale R; Properzi G; Desideri G
    Curr Pharm Des; 2007; 13(16):1631-45. PubMed ID: 17584094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat percentage is more strongly associated with biomarkers of low-grade inflammation than traditional cardiometabolic risk factors in healthy young adults - the Lifestyle, Biomarkers, and Atherosclerosis study.
    Pettersson-Pablo P; Nilsson TK; Breimer LH; Hurtig-Wennlöf A
    Scand J Clin Lab Invest; 2019 May; 79(3):182-187. PubMed ID: 30767573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of C-reactive protein in atherogenesis].
    Boncler M; Luzak B; Watala C
    Postepy Hig Med Dosw (Online); 2006; 60():538-46. PubMed ID: 17060895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings.
    Mugabo Y; Li L; Renier G
    Curr Diabetes Rev; 2010 Jan; 6(1):27-34. PubMed ID: 20034371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory markers in coronary artery disease.
    Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
    Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
    Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
    Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and other agents for vascular inflammation.
    Owens CD
    J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory biomarkers in stable atherosclerosis.
    Kinlay S; Egido J
    Am J Cardiol; 2006 Dec; 98(11A):2P-8P. PubMed ID: 17126676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of Atherosclerosis: Part 1 - Serological Markers.
    Tibaut M; Caprnda M; Kubatka P; Sinkovič A; Valentova V; Filipova S; Gazdikova K; Gaspar L; Mozos I; Egom EE; Rodrigo L; Kruzliak P; Petrovic D
    Heart Lung Circ; 2019 May; 28(5):667-677. PubMed ID: 30468147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
    Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
    Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Markers Related to Innate and Adaptive Immunity in Atherosclerosis: Implications for Disease Prediction and Prospective Therapeutics.
    Hong LZ; Xue Q; Shao H
    J Inflamm Res; 2021; 14():379-392. PubMed ID: 33628042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP and the risk of atherosclerotic events.
    Calabrò P; Golia E; Yeh ET
    Semin Immunopathol; 2009 Jun; 31(1):79-94. PubMed ID: 19415283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers of vascular inflammation in dyslipemia.
    Francisco G; Hernández C; Simó R
    Clin Chim Acta; 2006 Jul; 369(1):1-16. PubMed ID: 16469304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.